Doctor profile · Federal record

Dr. Melina Roman-Gerardino, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Internal Medicine Physician · Hospitalist Physician · New Orleans, LA

  • NPI 1770774804
  • Accepts Medicare
  • MIPS 88.9 / 100 · 2023
  • 19 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3525 Prytania St Ste 402
New Orleans, LA 701153585
(504) 648-2520
fax (504) 897-2939
Mailing address
3600 Prytania St Ste 35
New Orleans, LA 701153678

Credentials & registration

NPPES · NUCC
NPI registered
August 2007 — 19 yrs on file
Profile last updated
May 19, 2021
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Louisiana #MD.203002
Medicaid (2)
LA #1000990 · MS #01122754

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1770774804. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
451
Distinct HCPCS
5
Medicare allowed
$52,288
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 320 202 $126
99213 Established patient office or other outpatient visit, 20-29 minutes 59 50 $89
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 37 27 $34
99204 New patient office or other outpatient visit, 45-59 minutes 23 23 $165
10005 Fine needle aspiration biopsy using ultrasound guidance, first growth 12 12 $135

In context: peer comparison

Among 4 peers in this city , average services per provider: 69. This provider delivers 6.5× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,678
Transactions
68
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 13 $262.19
Novo Nordisk Inc 12 $232.13
BETA BIONICS, INC. 2 $153.17
Abbott Laboratories 6 $140.08
Mannkind Corporation 4 $125.09
Boehringer Ingelheim Pharmaceuticals, Inc. 7 $115.06
Xeris Pharmaceuticals, Inc. 3 $79.09
Medtronic, Inc. 2 $78.08
Bayer Healthcare Pharmaceuticals Inc. 4 $64.47
PFIZER INC. 3 $64.06
Amgen Inc. 3 $61.84
Lilly USA, LLC 3 $56.07
Corcept Therapeutics 2 $44.88
Dexcom, Inc. 2 $43.87
Amneal Pharmaceuticals LLC 2 $41.23

By nature of payment

Food and Beverage
$1,678

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,401
Patients
666
Total drug cost
$1,124,506
Drug Type Claims Patients Total cost
Synthroid (Levothyroxine Sodium) Brand 333 81 $32,470
Trulicity (Dulaglutide) Brand 323 72 $410,619
Levothyroxine Sodium Generic 283 95 $4,593
Jardiance (Empagliflozin) Brand 250 61 $218,735
Metformin Hcl Generic 187 61 $1,892
Mounjaro (Tirzepatide) Brand 158 40 $194,885
Methimazole Generic 136 39 $2,289
Metformin Hcl Er (Metformin Hcl) Brand 134 55 $1,126
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 103 32 $48,659
Cinacalcet Hcl Generic 93 22 $25,555

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Melina Roman-Gerardino's medical specialty?
Dr. Melina Roman-Gerardino practices Endocrinology, Diabetes & Metabolism Physician in New Orleans, LA.
Where does Dr. Melina Roman-Gerardino practice?
Dr. Melina Roman-Gerardino practices at 3525 Prytania St Ste 402, New Orleans, LA 701153585. Office phone: 5046482520.
What is Dr. Melina Roman-Gerardino's NPI?
Dr. Melina Roman-Gerardino's National Provider Identifier (NPI) is 1770774804, issued by NPPES.
Does Dr. Melina Roman-Gerardino accept Medicare assignment?
Yes. Dr. Melina Roman-Gerardino accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melina Roman-Gerardino commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.